Development and processing of molecular-biological diagnostic kits for rapid and sensitive diagnosis of viruses and bacteria causing human and animal diseases.
Environmentally friendly semi solid preparation from natural ecological sources will be created. This qualitatively new cream will retard cell aging, strengthen the antimicrobial barrier of the skin and promote healthy healing.
Creation of the methodology for natural antioxidant usage in preventing the development of diabetes mellitus complications. Estimation of new usage aspects of nutrition supplements. Optimisation of technological forms.
Development and validation of a prediction algorithm for rationalisation of the dosing strategies for higher risk drugs
To develop a robust point of care test for monitoring the effect of cancer therapy, based on antibodies directed to a patented peptide involved in cell proliferation.
Vegf kinoid anti-angiogenesis novel vaccine candidate: the accelerated development as an add-on treatment of colorectal cancer should offer a more cost-effective and convenient administration and dosage when compared to competing treatments.
The photochemical internalisation (pci) technology will be used for site-specific enhancement of the therapeutic effect of anti-cancer drugs in a clinical trial on patients with head, neck and other types of cancer
Development of novel detectors for positron emission tomography, based on new scintillators and silicon light sensors, with superior spatial resolution and time-of-flight capability, enabling improved image quality and shorter scans times.
Evogene and biogemaa are engaging in a multiyear collaboration project to deliver corn varieties with improved tolerance to abiotic stress (mainly drought resistance) using gene constructs which have been demonstrated in other plants.
We aim to develop antigen specific t cells against different muc1 glycoforms by means of differentiating stem cells in an artificial thymus towards dcs and t cells. These dcs will be transduced with ad-muc1 and given to t cells to generate antigen specific t cells that can be cloned.